ConductScience.org, home

Paper12500513

The influence of methylene blue infusion on cytokine levels during severe sepsis.

Memis D and 4 others. Anaesth Intensive Care, 2002. Cited by 73 papers, by iCite.

Cite this record

ConductScience Library. The influence of methylene blue infusion on cytokine levels during severe sepsis. Papers, record 12500513. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12500513

Download JSON
Disease
Sepsis231 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The influence of methylene blue infusion on cytokine levels during severe sepsis.
PubMed
Journal
Anaesth Intensive Care
PubMed
Year
2002
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
73
iCite
Relative citation ratio, by iCite
1.99
iCite
Revised in PubMed
2019-03-19
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Memis DD
2Karamanlioglu BB
3Yuksel MM
4Gemlik II
5Pamukcu ZZ

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CytokinesMajor topic
Methylene BlueMajor topic
SepsisMajor topic
Adult
Aged
Aged, 80 and over
Cyclic GMP
Double-Blind Method
Enzyme Inhibitors
Female
Hemodynamics
Humans
Infusions, Intravenous
Interleukins
Male
Methemoglobin
Middle Aged
Prospective Studies
Tumor Necrosis Factor-alpha

Source PubMed

Download CSV of topics

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT03120637Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene BlueResultsClinicalTrials.gov
NCT06306001Intravenous Methylene Blue for Treating Refractory Neonatal Septic ShockResultsClinicalTrials.gov
NCT07040540Hemodynamic Effects of Intradermal Methylene Blue During Breast Surgery Under General AnesthesiaBackgroundClinicalTrials.gov

Download CSV of trials

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.

PMIDTitleJournalYearIn PapersSource
42355649The Effectiveness of Methylene Blue in Adult Shock: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials.J Clin Med2026https://conductscience.org/library/papers/42355649PubMed
42165863Assessment of methylene blue and NAD on LPS-induced acute brain injury: effects on neuroinflammation, oxidative stress, and blood-brain barrier integrity in a rat endotoxemia model.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42165863PubMed
41689248Methylene Blue Rescue Therapy for Vasoplegic Shock After Antihypertensive Drug Overdose.Am J Case Rep2026https://conductscience.org/library/papers/41689248PubMed
40870501Methylene Blue Alleviates Inflammatory and Oxidative Lung Injury in a Rat Model of Feces-Induced Peritonitis.Medicina (Kaunas)2025https://conductscience.org/library/papers/40870501PubMed
40764469Hemolysis, hemolytic markers, and mortality in sepsis: a scoping review.Intensive Care Med Exp2025https://conductscience.org/library/papers/40764469PubMed
40718345Methylene Blue in Septic Shock: Emerging Evidence, Clinical Applications, and Future Directions.Cureus2025https://conductscience.org/library/papers/40718345PubMed
40110157Blue Hopes, Red Flags: The Methylene Blue Dilemma in Sepsis Shock.Indian J Crit Care Med2025https://conductscience.org/library/papers/40110157PubMed
40021734Predicting responsiveness to fixed-dose methylene blue in adult patients with septic shock using interpretable machine learning: a retrospective study.Sci Rep2025https://conductscience.org/library/papers/40021734PubMed
39816212Haemodynamic management of septic shock.Burns Trauma2025https://conductscience.org/library/papers/39816212PubMed
39780053Comparative study between high and low dose methylene blue infusion in septic cancer patients: a randomized, blinded, controlled study.BMC Anesthesiol2025https://conductscience.org/library/papers/39780053PubMed
39736782Non-adrenergic vasopressors for vasodilatory shock or perioperative vasoplegia: a meta-analysis of randomized controlled trials.Crit Care2024https://conductscience.org/library/papers/39736782PubMed
39476299Fifty shades of green and blue: autopsy findings after administration of xenobiotics.Forensic Sci Med Pathol2025https://conductscience.org/library/papers/39476299PubMed
39360775Major Publications in the Critical Care Pharmacotherapy Literature: 2023.Crit Care Explor2024https://conductscience.org/library/papers/39360775PubMed
39334256Efficacy of methylene blue in refractory septic shock: study protocol for a multicenter, randomized, placebo-controlled trial.Trials2024https://conductscience.org/library/papers/39334256PubMed
38904978Methylene Blue in Septic Shock: A Systematic Review and Meta-Analysis.Crit Care Explor2024https://conductscience.org/library/papers/38904978PubMed
38698779Methylene blue in sepsis and septic shock: a systematic review and meta-analysis.Front Med (Lausanne)2024https://conductscience.org/library/papers/38698779PubMed
38365828Administration of methylene blue in septic shock: pros and cons.Crit Care2024https://conductscience.org/library/papers/38365828PubMed
38216185Effect of methylene blue on outcomes in patients with distributive shock: a meta-analysis of randomised controlled trials.BMJ Open2024https://conductscience.org/library/papers/38216185PubMed
37719353Can Use of Intravenous Methylene Blue Improve the Hemodynamics and Outcome of the Patients with Refractory Septic Shock? An Observational Study.Indian J Crit Care Med2023https://conductscience.org/library/papers/37719353PubMed
37670332Drug diluent and efficacy of methylene blue in septic shock: authors' reply.Crit Care2023https://conductscience.org/library/papers/37670332PubMed

See all 35 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
IL1A3552PubTator's text mininghttps://conductscience.org/library/genes/3552NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
METHYLENE BLUECHEMBL550495Results2https://conductscience.org/library/drugs/CHEMBL550495

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12500513

GET https://conductscience.org/api/papers/v1/12500513/cited_by?page=2